|
|
|
Volumn 11, Issue 5, 2010, Pages 495-498
|
|
Is PDE4 too difficult a drug target?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 [2 [3 (CYCLOPENTYLOXY) 4 METHOXYPHENYL] 2 PHENYLETHYL]PYRIDINE;
AN 2898;
ANTIINFLAMMATORY AGENT;
APREMILAST;
ATIZORAM;
CILOMILAST;
CIPAMFYLLINE;
IBUDILAST;
MILRINONE;
MK 0359;
PHOSPHODIESTERASE IV;
PHOSPHODIESTERASE IV INHIBITOR;
PICLAMILAST;
ROFLUMILAST;
ROLIPRAM;
SILDENAFIL;
THEOPHYLLINE;
UNCLASSIFIED DRUG;
ALLERGIC RHINITIS;
ANTIINFLAMMATORY ACTIVITY;
ASTHMA;
ATOPIC DERMATITIS;
CARDIOTOXICITY;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG TARGETING;
DRUG TOLERABILITY;
GASTROINTESTINAL SYMPTOM;
HEART FAILURE;
HUMAN;
MALE SEXUAL DYSFUNCTION;
MENTAL DISEASE;
NAUSEA;
NAUSEA AND VOMITING;
PSORIASIS;
REVIEW;
SIDE EFFECT;
TACHYCARDIA;
THERAPY EFFECT;
WAKEFULNESS;
ANTI-INFLAMMATORY AGENTS;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
PHOSPHODIESTERASE INHIBITORS;
|
|
EID: 77952192978
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (24)
|
|
References (0)
|
